» Articles » PMID: 26079412

Development of a Patient-reported Outcome Instrument to Assess Complex Activities of Daily Living and Interpersonal Functioning in Persons with Mild Cognitive Impairment: The Qualitative Research Phase

Overview
Specialties Neurology
Psychiatry
Date 2015 Jun 17
PMID 26079412
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: As drug development research efforts move toward studying patients earlier in the course of Alzheimer's disease (AD), it is important to incorporate the patient's perspective into measurement of outcomes.

Methods: This article summarizes the qualitative work of the Patient-Reported Outcome Consortium's Cognition Working Group in the development of a new self-reported outcome measure in persons with mild cognitive impairment (MCI) due to suspected AD, herein referred to as MCI.

Results: The draft measure captures the patient's voice for two functional domains, complex activities of daily living and interpersonal functioning.

Discussion: This work represents a series of initial steps in the development of this rating scale. The next steps are to conduct psychometric analysis and evaluate the role of insight.

Citing Articles

Defining benefit: Clinically and biologically meaningful outcomes in the next-generation Alzheimer's disease clinical care pathway.

Elhage A, Cohen S, Cummings J, van der Flier W, Aisen P, Cho M Alzheimers Dement. 2024; 21(2):e14425.

PMID: 39697158 PMC: 11848336. DOI: 10.1002/alz.14425.


Towards new perspectives: A scoping review and meta-synthesis to redefine brain health for multiple sclerosis.

Wills O, Probst Y Eur J Neurol. 2024; 31(6):e16210.

PMID: 38226556 PMC: 11235954. DOI: 10.1111/ene.16210.


Unexpected lucidity in dementia: application of qualitative methods to develop an informant-reported lucidity measure.

Ramirez M, Teresi J, Ellis J, Gonzalez-Lopez P, Silver S, Rutigliano M Aging Ment Health. 2023; 27(12):2395-2402.

PMID: 37145967 PMC: 10592548. DOI: 10.1080/13607863.2023.2207167.


Assessing What Matters to People Affected by Alzheimer's Disease: A Quantitative Analysis.

Hauber B, Paulsen R, Krasa H, Vradenburg G, Comer M, Callahan L Neurol Ther. 2023; 12(2):505-527.

PMID: 36763306 PMC: 10043143. DOI: 10.1007/s40120-023-00445-0.


Outcome measures for Alzheimer's disease: A global inter-societal Delphi consensus.

Ellison T, Cappa S, Garrett D, Georges J, Iwatsubo T, Kramer J Alzheimers Dement. 2023; 19(6):2707-2729.

PMID: 36749854 PMC: 11010236. DOI: 10.1002/alz.12945.